Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury
Anna Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Julio L. Sampaio, Daniele Malpetti, Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet
Anna Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Julio L. Sampaio, Daniele Malpetti, Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet
View: Text | PDF
Research Article Nephrology Transplantation

Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury

  • Text
  • PDF
Abstract

Energy metabolism failure in proximal tubule cells (PTCs) is a hallmark of chronic kidney injury. We combined transcriptomic, metabolomic, and lipidomic approaches in experimental models and patient cohorts to investigate the molecular basis of the progression to chronic kidney allograft injury initiated by ischemia/reperfusion injury (IRI). The urinary metabolome of kidney transplant recipients with chronic allograft injury and who experienced severe IRI was substantially enriched with long chain fatty acids (FAs). We identified a renal FA-related gene signature with low levels of carnitine palmitoyltransferase 2 (Cpt2) and acyl-CoA synthetase medium chain family member 5 (Acsm5) and high levels of acyl-CoA synthetase long chain family member 4 and 5 (Acsl4 and Acsl5) associated with IRI, transition to chronic injury, and established chronic kidney disease in mouse models and kidney transplant recipients. The findings were consistent with the presence of Cpt2–Acsl4+Acsl5+Acsm5– PTCs failing to recover from IRI as identified by single-nucleus RNA-Seq. In vitro experiments indicated that ER stress contributed to CPT2 repression, which, in turn, promoted lipids’ accumulation, drove profibrogenic epithelial phenotypic changes, and activated the unfolded protein response. ER stress through CPT2 inhibition and lipid accumulation engaged an auto-amplification loop leading to lipotoxicity and self-sustained cellular stress. Thus, IRI imprints a persistent FA metabolism disturbance in the proximal tubule, sustaining the progression to chronic kidney allograft injury.

Authors

Anna Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Julio L. Sampaio, Daniele Malpetti, Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet

×

Figure 3

Dysregulation of FA metabolism persists in PTCs not recovering after AKI.

Options: View larger image (or click on image) Download as PowerPoint
Dysregulation of FA metabolism persists in PTCs not recovering after AKI...
(A) Uniform manifold approximation and projection (UMAP) (left panel) and dot plot (right panel) representation of the PTCs (n = 27,148 nuclei) selected from pooled mouse IRI and control kidney samples analyzed at different time points by snRNA-Seq. PTCs are depicted according to the definition of cell states based on the relative expression of differentiation markers (Lrp2, Slc5a2, Slc13a3, Slc16a9) and stress markers (Havcr1 and Vcam1) and the time points: normal PT (positive for Lrp2, Slc5A2, Slc13a3, Slc16a9 before injury), early injured PT (Havcr1 positive at 4 hours, 12 hours, 48 hours after IRI), recovered PT (positive for Lrp2, Slc5A2, Slc13a3, Slc16a9 at 14 days and 6 weeks), and persistent injured PT (positive for Havcr1, Vcam1 at 14 days and 6 weeks). (B) Expression levels of Cpt2, Acsl4, Acsl5, and Acsm5 in normal PT, early injured PT, recovered PT, and persistent injured PT. Box plots depict gene expression after application of Markov Affinity-based Graph Imputation of Cells (MAGIC). The box plots depict the minimum and maximum values (whiskers), the upper and lower quartiles, and the median. The length of the box represents the interquartile range. Pairwise comparisons using Wilcoxon rank sum test with continuity correction exhibit significant differences in gene expression among the different PTC clusters. (C) FeaturePlot representation of the expression of Cpt2, Acsl4, Acsl5, and Acsm5 in PTCs (n = 27,148 nuclei) selected from pooled mouse IRI and control kidney samples analyzed at different time points by snRNA-Seq. (D) FeaturePlot highlights in red (n = 92 dots) the PTCs with normalized gene expression of Acsl4 > 0.2 and Cpt2 < 0.05 and Acsl5 > 0.2 and Acsm5 < 0.05 (full house signature). (E) Receiver operating characteristic curve, and its underlying area (AUROC), for a model (logistic regression) predicting the binary ci score (ci ≤ 1 vs. ci > 1) 12 months after transplantation, using the expression levels of ACSL4, ACSL5, ACSM5, and CPT2 in kidney allografts 3 months after transplantation. n = 41. P value has been calculated with a Mann-Whitney U test. TPR, true positive rate; FPR, false positive rate.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts